Primary analysis of a phase II randomized trial Radiation Therapy Oncology Group (RTOG) 0212: impact of different total doses and schedules of prophylactic cranial irradiation on chronic neurotoxicity and quality of life for patients with limited-disease small-cell lung cancer.
OBJECTIVE
To determine the effect of dose and fractionation schedule of prophylactic cranial irradiation (PCI) on the incidence of chronic neurotoxicity (CNt) and changes in quality of life for selected patients with limited-disease small-cell lung cancer (LD SCLC).


METHODS
Patients with LD SCLC who achieved a complete response after chemotherapy and thoracic irradiation were eligible for randomization to undergo PCI to a total dose of 25 Gy in 10 daily fractions (Arm 1) vs. the experimental cohort of 36 Gy. Those receiving 36 Gy underwent a secondary randomization between daily 18 fractions (Arm 2) and twice-daily 24 fractions (Arm 3). Enrolled patients participated in baseline and follow-up neuropsychological test batteries along with quality-of-life assessments.


RESULTS
A total of 265 patients were accrued, with 131 in Arm 1, 67 in Arm 2, and 66 in Arm 3 being eligible. There are 112 patients (42.2%) alive with 25.3 months of median follow-up. There were no significant baseline differences among groups regarding quality-of-life measures and one of the neuropsychological tests, namely the Hopkins Verbal Learning Test. However, at 12 months after PCI there was a significant increase in the occurrence of CNt in the 36-Gy cohort (p=0.02). Logistic regression analysis revealed increasing age to be the most significant predictor of CNt (p=0.005).


CONCLUSIONS
Because of the increased risk of developing CNt in study patients with 36 Gy, a total PCI dose of 25 Gy remains the standard of care for patients with LD SCLC attaining a complete response to initial chemoradiation.
Wolfson
Aaron H
AH
Department of Radiation Oncology, University of Miami Miller School of Medicine, Miami, FL 33136, USA. awolfson@med.miami.edu
Bae
Kyounghwa
K
Komaki
Ritsuko
R
Meyers
Christina
C
Movsas
Benjamin
B
Le Pechoux
Cecile
C
Werner-Wasik
Maria
M
Videtic
Gregory M M
GM
Garces
Yolanda I
YI
Choy
Hak
H
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001921:Brain / Q000528:radiation effects*; D001932:Brain Neoplasms / Q000517:prevention & control*; D002908:Chronic Disease; D016371:Cranial Irradiation; D019583:Dose Fractionation, Radiation; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy / Q000473:pathology / Q000532:radiotherapy*; D008875:Middle Aged; D009483:Neuropsychological Tests; D011788:Quality of Life; D012044:Regression Analysis; D055752:Small Cell Lung Carcinoma / Q000188:drug therapy / Q000517:prevention & control / Q000532:radiotherapy* / Q000556:secondary
J Consult Clin Psychol. 1991 Feb;59(1):12-9
2002127
J Eval Clin Pract. 2000 Feb;6(1):39-49
10807023
Lancet Oncol. 2009 May;10(5):467-74
19386548
Cancer. 2008 Feb 1;112(3):589-95
18098269
Eur J Cancer. 1997 Oct;33(11):1752-8
9470828
Am J Clin Oncol. 1998 Feb;21(1):84-90
9499267
J Clin Oncol. 1994 Nov;12(11):2327-32
7964948
Neuro Oncol. 2003 Apr;5(2):89-95
12672280
J Clin Oncol. 1990 Jan;8(1):48-56
2153196
Int J Radiat Oncol Biol Phys. 1996 Mar 15;34(5):1037-44
8600086
Cancer Invest. 1988;6(6):669-76
2854492
Am J Clin Oncol. 2001 Jun;24(3):290-5
11404503
Qual Life Res. 1993 Apr;2(2):129-40
8518767
N Engl J Med. 1999 Aug 12;341(7):476-84
10441603
Int J Radiat Oncol Biol Phys. 1995 Aug 30;33(1):179-82
7642416
Semin Radiat Oncol. 1995 Jan;5(1):61-68
10717128
Mayo Clin Proc. 1999 May;74(5):461-5
10319075
Cancer. 1987 Nov 1;60(9):2275-83
2830955
Qual Life Res. 1993 Jun;2(3):193-203
8401455
Semin Oncol. 1997 Aug;24(4):477-83
9280227
Qual Life Res. 1996 Feb;5(1):139-50
8901377
J Natl Cancer Inst. 1993 Mar 3;85(5):365-76
8433390
Cancer Treat Rep. 1981 Sep-Oct;65(9-10):811-4
6268295
J Support Oncol. 2004 Mar-Apr;2(2):127-32; discussion 133-5, 138-40
15328816
Acta Oncol. 1992;31(3):311-21
1622651
Acta Oncol. 1992;31(1):19-28
1316770
Qual Life Res. 1994 Oct;3(5):353-64
7841968
Lung Cancer. 1995 Jun;12(3):231-5
7655832
Int J Radiat Oncol Biol Phys. 1982 Feb;8(2):219-26
7085377
Qual Life Res. 1993 Oct;2(5):319-25
8136796
Qual Life Res. 1997 Mar;6(2):103-8
9161109
J Clin Oncol. 1995 May;13(5):1249-54
7738629
J Clin Oncol. 1998 May;16(5):1954-60
9586915
Int J Radiat Oncol Biol Phys. 1995 Feb 15;31(4):911-4
7860405
Oncology (Williston Park). 1998 Jan;12(1 Suppl 2):19-24
9516607
Am J Clin Oncol. 1989 Feb;12(1):27-33
2536214